PATENT CLAIM ANALYSIS

Application Number: 15750068
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "230800"]

Abstract:
The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.

Claim (Index 7):
A stable, liquid parenteral pharmaceutical formulation of  claim 4 , wherein pH adjusting agents and buffering agents are selected from phosphate buffer, citrate buffer, sodium carbonate, sodium bicarbonate, tartarate, benzoate, lactate, acetate, borate, glutaric acid, malic acid, succinic acid and carbonic acid, alkali or alkaline earth salt of one of these acids, Tris, histidine, meglumine, amino acids, sodium hydroxide, potassium hydroxide, hydrochloric acid and citric acid.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 88.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15342445', '15886247', '14242973', '15611785', '12434499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668072159317637
- 35 USC 102 Novelty (BERT): 0.4971278260954781
- Combined Prediction Score: 0.7398392769481351
- Mean Citation Score: 202.820424
- Max Citation Score: 253.53969
- Similarity Product: 201.7457208543134

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test